SCHEMBL6934556

SCHEMBL6934556

O=C(O)CN(CC(=O)O)c1ccc([Te]c2ccc(N(CC(=O)O)CC(=O)O)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.37
PLA2G2A P14555 1/20 0.36
BLM P54132 1/20 0.36
KEAP1 Q14145 2/20 0.35
NFE2L2 Q16236 2/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
GMNN O75496 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
GABRA1 P14867 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34
THPO P40225 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
PMP22 Q01453 1/20 0.34
HIF1A Q16665 1/20 0.34
SLCO1B3 Q9NPD5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8038936 0.87 TDP1 (0.44) TDP1PLA2G2ABLMKEAP1NFE2L2
SCHEMBL342249 0.81 ALDH1A1 (0.44) TDP1BLMKEAP1NFE2L2SMN1; SMN2
SCHEMBL13645018 0.78 CA2 (0.46) TDP1PLA2G2ABLMALDH1A1LMNA
SCHEMBL202173 0.78 TDP1 (0.50) TDP1PLA2G2ABLMSMN1; SMN2ALDH1A1
SCHEMBL9974573 0.77 KEAP1 (0.56) KEAP1NFE2L2SMN1; SMN2ALDH1A1RAB9A
SCHEMBL341751 0.77 TDP1 (0.50) TDP1PLA2G2ABLMKEAP1NFE2L2
SCHEMBL18360374 0.77 POLB (0.44) TDP1PLA2G2ABLMSMN1; SMN2GMNN
SCHEMBL4142849 0.77 TDP1 (0.42) TDP1KEAP1NFE2L2ALDH1A1MAPT
SCHEMBL340532 0.77 MEN1 (0.42) TDP1KEAP1NFE2L2ALDH1A1MAPT
SCHEMBL13644976 0.77 ALDH1A1 (0.50) TDP1SMN1; SMN2ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0747704-B1 Immunoassay element containing a diaryl telluride compound to increase its stability ORTHO CLINICAL DIAGNOSTICS INC (US) 2003-12-10 EP disclosed
EP-0903583-B1 Reduction in first slide bias and improved enzyme stability by incorporation of diaryl tellurides in the gravure layer of dry-film immunoassay elements ORTHO CLINICAL DIAGNOSTICS INC (US) 2003-11-12 EP disclosed
US-5928886-A SUPPORT HAVING ZONE OF ENZYME LABELED LIGAND OR ENZYME LABELED RECEPTOR, SPREADING ZONE, ZONE OF IMMOBILIZED RECEPTOR OF LIGAND, AND GRAVURE ZONE WITH DIARYL TELLURIDE; INCREASED STORAGE STABILITY JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) 1999-07-27 US disclosed
EP-0903583-A2 Reduction in first slide bias and improved enzyme stability by incorporation of diaryl tellurides in the gravure layer of dry-film immunoassay elements Ortho-Clinical Diagnostics, Inc. (US) 1999-03-24 EP disclosed
US-5686254-A Reduction in first slide bias and improved enzyme stability by the incorporation of diaryl tellurides in thin-film immunoassay elements JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) 1997-11-11 US disclosed
EP-0747704-A2 Immunoassay element containing a diaryl telluride compound to increase its stability Johnson & Johnson Clinical Diagnostics, Inc. (US) 1996-12-11 EP disclosed